SUBSCRIBE
SUBSCRIBE

Vaccines

Drug Development
Pfizer Owes Massive $14.6 Billion Q1 Revenues to Vaccine Rollout
Pfizer reported its first-quarter 2021 revenues of $14.6 billion, an impressive 42% operational growth.
May 4, 2021
 · 
3 min read
 · 
Mark Terry
Bio NC
2021 COVID-19 News: Pfizer to File for Full Approval of Its Vaccine and More
Please check out the biopharma industry’s COVID-19 stories that are trending for May 4, 2021.
May 4, 2021
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Australian Researchers Say Best COVID-19 Vaccines 58% Effective at 250 Days
Next year, people are likely to need an annual COVID-19 vaccination just like they need an annual flu shot.
May 4, 2021
 · 
5 min read
 · 
Gail Dutton
Tayfun Coskun/Anadolu Agency via Getty Images
Drug Development
Touting 100% Efficacy, Pfizer Vaccine Expects Approval This Week for Younger Teens
The U.S. FDA is expected to give the go-ahead for Pfizer and BioNTech’s COVID-19 vaccine for adolescents ages 12 and older within the week.
May 4, 2021
 · 
2 min read
 · 
Mark Terry
Load More
PRESS RELEASES
Press Releases
Osivax Receives $19.5M BARDA Award to Advance Next-Generation Influenza Vaccine for Pandemic and Seasonal Preparedness
August 26, 2025
 · 
3 min read
Press Releases
Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology
August 25, 2025
 · 
7 min read
Press Releases
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
August 25, 2025
 · 
6 min read
Press Releases
Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
August 22, 2025
 · 
4 min read
Press Releases
Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile
August 22, 2025
 · 
9 min read
Press Releases
Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
August 21, 2025
 · 
5 min read
Press Releases
Scientists Discuss the Recent CancerVax Breakthrough
August 19, 2025
 · 
5 min read
Press Releases
Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine
August 19, 2025
 · 
6 min read
Press Releases
Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
August 18, 2025
 · 
3 min read
Press Releases
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in Canada for Individuals Aged 12 and Older
August 18, 2025
 · 
6 min read
Press Releases
FLUMIST (Influenza, Vaccine Live, Intranasal), the nation’s only nasal spray flu vaccine, now available for home delivery
August 18, 2025
 · 
10 min read
Press Releases
Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19
August 15, 2025
 · 
14 min read
Press Releases
IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma
August 11, 2025
 · 
1 min read
Press Releases
Turn Therapeutics Intranasal Vaccine Candidate Demonstrates Extended Stability
August 7, 2025
 · 
3 min read
Press Releases
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
August 7, 2025
 · 
5 min read
Press Releases
Appili Therapeutics and Colleagues Publish Manuscript Demonstrating Efficacy of ATI-1701 Tularemia Vaccine
August 6, 2025
 · 
5 min read
Press Releases
CancerVax Successfully Disguises Cancer Cells and Tricks Immune Cells into Attacking Them
August 5, 2025
 · 
5 min read
Press Releases
Phase 1 Clinical Ttrial of HIV Vaccine Starts in Africa to Evaluate Immune Responses to Highly Networked HIV T-Cell Epitopes
August 5, 2025
 · 
5 min read
Press Releases
Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial
August 5, 2025
 · 
4 min read
Press Releases
Evidence review suggests COVID-19 vaccines safe for pregnant women and their babies
August 1, 2025
 · 
2 min read
Load More